The HLA-DRB1 and HLA-DQB1 alleles are associated with multiple sclerosis disability progression in Slovak population

References

• Compston A, Coles A. Multiple sclerosis. Lancet. 2008;372(9648):1502–1517.10.1016/S0140-6736(08)61620-7
   PubMed Web of Science ®Google Scholar
• Levin MC, Douglas JN, Meyers L, et al. Neurodegeneration in multiple sclerosis involves multiple pathogenic mechanisms. Degener Neurol Neuromuscul Dis. 2014;2014(4):49–63.10.2147/DNND
   Google Scholar
• Kakalacheva K, Lünemann JD. Environmental triggers of multiple sclerosis. FEBS Lett. 2011;585(23):3724–3729.10.1016/j.febslet.2011.04.006
   PubMed Web of Science ®Google Scholar
• Hafler DA, Compston A, Sawcer S, et al. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med. 2007;357(9):851–862.
   PubMed Web of Science ®Google Scholar
• Bashinskaya VV, Kulakova OG, Boyko AN, et al. A review of genome-wide association studies for multiple sclerosis: classical and hypothesis-driven approaches. Hum Genet. 2015;134(11–12):1143–1162.10.1007/s00439-015-1601-2
   PubMed Web of Science ®Google Scholar
• Nischwitz S, Mu ller-Myhsok B, Weber F. Risk conferring genes in multiple sclerosis. FEBS Lett. 2011;585(23):3789–3797.10.1016/j.febslet.2011.03.037
   PubMed Web of Science ®Google Scholar
• International Multiple Sclerosis Genetics Consortium; Wellcome Trust Case Control Consortium 2, Sawcer S, Hellenthal G, Pirinen M, et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature. 2011;476(7359):214–219.10.1038/nature10251
   PubMed Web of Science ®Google Scholar
• Choo SY. The HLA system: genetics, immunology, clinical testing, and clinical implications. Yonsei Med J. 2007;48(1):11–23.10.3349/ymj.2007.48.1.11
   PubMed Web of Science ®Google Scholar
• Cresswell P. Assembly, transport, and function of MHC class II molecules. Annu Rev Immunol. 1994;12:259–291.10.1146/annurev.iy.12.040194.001355
   PubMed Web of Science ®Google Scholar
• Stinissen P, Hellings N. Activation of myelin reactive T cells in multiple sclerosis: A possible role for T cell degeneracy? Eur J Immunol. 2008;38(5):1190–1193.10.1002/(ISSN)1521-4141
   PubMed Web of Science ®Google Scholar
• Dyment DA, Herrera BM, Cader MZ, et al. Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance. Hum Mol Genet. 2005;14:2019–2026.10.1093/hmg/ddi206
   PubMed Web of Science ®Google Scholar
• Ramagopalan SV, Morris AP, Dyment DA, et al. The inheritance of resistance alleles in multiple sclerosis. PLoS Genet. 2007;3(9):e150.10.1371/journal.pgen.0030150
   PubMed Web of Science ®Google Scholar
• Zhang Q, Lin CY, Dong Q, et al. Relationship between HLA-DRB1 polymorphism and susceptibility or resistance to multiple sclerosis in Caucasians: a meta-analysis of non-family-based studies. Autoimmun Rev. 2011;10(8):474–481.10.1016/j.autrev.2011.03.003
   PubMed Web of Science ®Google Scholar
• Barcellos LF, Sawcer S, Ramsay PP, et al. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis. Hum Mol Genet. 2006;15(18):2813–2824.10.1093/hmg/ddl223
   PubMed Web of Science ®Google Scholar
• Schmidt H, Williamson D, Ashley-Koch A. HLA-DR15 haplotype and multiple sclerosis: a HuGE review. Am J Epidemiol. 2007;165(10):1097–1109.10.1093/aje/kwk118
   PubMed Web of Science ®Google Scholar
• Michalik J, Čierny D, Kantorová E, et al. The association of HLA-DRB1 and HLA-DQB1 alleles with genetic susceptibility to multiple sclerosis in the Slovak population. Neurol Res. 2015;37(12):1060–1067.10.1080/01616412.2015.1115212
   PubMed Web of Science ®Google Scholar
• DeLuca GC, Ramagopalan SV, Herrera BM, et al. An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locus. Proc Nat Acad Sci. 2007;104(52):20896–20901.10.1073/pnas.0707731105
   PubMed Web of Science ®Google Scholar
• Silva AM, Pereira C, Bettencourt A, et al. The role of HLA-DRB1 alleles on susceptibility and outcome of a Portuguese Multiple Sclerosis population. J Neurol Sci. 2007;258(1–2):69–74.10.1016/j.jns.2007.02.033
   PubMed Web of Science ®Google Scholar
• Smestad C, Brynedal B, Jonasdottir G, et al. The impact of HLA-A and -DRB1 on age at onset, disease course and severity in Scandinavian multiple sclerosis patients. Eur J Neurol. 2007;14(8):835–840.10.1111/ene.2007.14.issue-8
   PubMed Web of Science ®Google Scholar
• Wu JS, James I, Qiu W, et al. HLA-DRB1 allele heterogeneity influences multiple sclerosis severity as well as risk in Western Australia. J Neuroimmunol. 2010;219(1–2):109–113.10.1016/j.jneuroim.2009.11.015
   PubMed Web of Science ®Google Scholar
• Romero-Pinel L, Pujal JM, Martínez-Yélamos S, et al. HLA-DRB1: genetic susceptibility and disability progression in a Spanish multiple sclerosis population. Eur J Neurol. 2011;18(2):337–342.10.1111/ene.2011.18.issue-2
   PubMed Web of Science ®Google Scholar
• Van der Walt A, Stankovich J, Bahlo M, et al. Heterogeneity at the HLA-DRB1 allelic variation locus does not influence multiple sclerosis disease severity, brain atrophy or cognition. Mult Scler. 2011;17(3):344–352.10.1177/1352458510389101
   PubMed Web of Science ®Google Scholar
• Balnyte R, Rastenyte D, Vaitkus A, et al. The importance of HLA DRB1 gene allele to clinical features and disability in patients with multiple sclerosis in Lithuania. BMC Neurology. 2013;13:938.10.1186/1471-2377-13-77
   Web of Science ®Google Scholar
• Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the ‘McDonald Criteria’. Ann Neurol. 2005;58(6):840–846.10.1002/(ISSN)1531-8249
   PubMed Web of Science ®Google Scholar
• Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69(2):292–302.10.1002/ana.22366
   PubMed Web of Science ®Google Scholar
• Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33(11):1444–1444.10.1212/WNL.33.11.1444
   PubMed Web of Science ®Google Scholar
• Roxburgh RH, Seaman SR, Masterman T, et al. Using disability and disease duration to rate disease severity. Multiple Sclerosis Severity Score. Neurology. 2005;64(7):1144–1151.
   PubMed Web of Science ®Google Scholar
• Masterman T, Ligers A, Olsson T, et al. HLA-DR15 is associated with lower age at onset in multiple sclerosis. Ann Neurol. 2000;48(2):211–219.10.1002/(ISSN)1531-8249
   PubMed Web of Science ®Google Scholar
• Deng L, Mariuzza RA. Recognition of self-peptide-MHC complexes by autoimmune T-cell receptors. Trends Biochem Sci. 2007;32(11):500–508.10.1016/j.tibs.2007.08.007
   PubMed Web of Science ®Google Scholar
• Valli A, Sette A, Kappos L, et al. Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients. J Clin Invest. 1993;91(2):616–628.10.1172/JCI116242
   PubMed Web of Science ®Google Scholar
• Wucherpfennig KW, Zhang J, Witek C, et al. Clonal expansion and persistence of human T cells specific for an immunodominant myelin basic protein peptide. J Immunol. 1994;152(11):5581–5592.
   PubMed Web of Science ®Google Scholar
• Ota K, Matsui M, Milford EL, et al. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature. 1990;346(6280):183–187.10.1038/346183a0
   PubMed Web of Science ®Google Scholar
• Mazza G, Ponsford M, Lowrey P, et al. Diversity and dynamics of the T-cell response to MBP in DR2+ve individuals. Clin Exp Immunol. 2002;128(3):538–547.10.1046/j.1365-2249.2002.01831.x
   PubMed Web of Science ®Google Scholar
• Okuda DT, Srinivasan R, Oksenberg JR, et al. Genotype-phenotype correlations in multiple sclerosis: HLA genes influence disease severity inferred by 1HMR spectroscopy and MRI measures. Brain. 2009;132(1):250–259.10.1093/brain/awn301
   PubMedGoogle Scholar
• Ramagopalan SV, Maugeri NJ, Handunnetthi L, et al. Expression of the multiple sclerosis-associated MHC class II allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Genet. 2009;5(2):e1000369.10.1371/journal.pgen.1000369
   PubMed Web of Science ®Google Scholar
• Lincoln MR, Ramagopalan SV, Chao MJ, et al. Epistasis among HLA-DRB1, HLA-DQA1, and HLA-DQB1 loci determines multiple sclerosis susceptibility. Proc Nat Acad Sci. 2009;106(18):7542–7547.10.1073/pnas.0812664106
   PubMed Web of Science ®Google Scholar
• Chao MJ, Ramagopalan SV, Herrera BM, et al. Epigenetics in multiple sclerosis susceptibility: difference in transgenerational risk localizes to the major histocompatibility complex. Hum Mol Genet. 2009;18(2):261–266.
   PubMed Web of Science ®Google Scholar